The administration calls for increased transparency and a more aggressive enforcement of rules against pharmaceutical companies.

President Donald J. Trump issued a memorandum on Tuesday, directing the Secretary of Health and Human Services and the Commissioner of Food and Drugs to take action against what he called “misleading” direct-to-consumer prescription drug advertisements.

The move is aimed at ensuring these ads provide “fair, balanced, and complete information” to the public.

The memorandum states that since the Food and Drug Administration (FDA) was given the authority to regulate drug advertising in 1962, the agency’s requirements have allowed for less information to be included in broadcast advertising.

According to the document, this has enabled drug companies to prioritize

See Full Page